RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Gesynta Pharma

Gesynta Pharma

Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and increase blood flow in the body’s microvasculature, thereby providing safe and efficacious treatments for several serious diseases.

Latest funding

$28M Series B+ ·

Led by Innovestor · Source: fundraisingfox.com

Latest round on record: Series B+, July 2025, amount undisclosed.

All 2 rounds ↓
Website: gesynta.se.
LinkedIn: gesynta-pharma.
Category: Health and bio.
Sectors: Biopharma, Health Care, Pharmaceutical.
Stage: Series B+.
Based in: Stockholm, Sweden.
Last round: Jul 23, 2025 · 481 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredMar 17, 2017 (9 years old)

Funding rounds

DateRoundAmountLeadSource
Series B+undisclosed—fundraisingfox.com
Series B+$28MIInnovestorfundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Gesynta Pharma

Other companies backed by Innovestor

Innovestor portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/gesynta-pharma (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy